20SProteasomeactivator 1 is a potent20Sproteasomeactivator withEC₂₀₀values of 0.3 μM, 0.7 μM and 1.8 μM for trypsin-like site, chymotrypsin-like site and caspase-like site. 20SProteasomeactivator 1 translates well in a cellular system, preventing the accumulation of the pathogenic A53T mutant ofα-synuclein. 20SProteasomeactivator 1 can be used for researching neurodegenerative diseases^[1].

IC₅₀: 0.3 μM (trypsin-like site), 0.7 μM (chymotrypsin-like site), 1.8 μM (caspase-like site)^[1]

20S Proteasome activator 1 (compound 19) (2.5-15 μM; 45 min) degrades 73% α-synuclein at 10 μM, and over 80% at 15 μM^[1].
20S Proteasome activator 1 (5-15 μM; 24 h) reduces 25% A53T mutant, and dose-dependently reduces enhancement of α-synuclein in Hek-293T cells (transiently transfected with an A53T mutant α-synuclein plasmid) at 5 μM; decreases 67% A53T α-synuclein at 15 μM^[1].

492.97

C₂₇H₁₉ClF₂N₂OS

2761578-18-9

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.